Filing Flows › Aytu Biopharma (AYTU) › Capital expenditures
Aytu Biopharma (AYTU) capital expenditures by quarter
Aytu Biopharma's capital expenditures were $12K in Q4 FY26 (fourth quarter fiscal 2026), -29% from Q2 FY26. Over the last 4 quarters it ranged from $6K (Q2 FY25) to $17K (Q2 FY26).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q4 FY26 | $12K | -29% | -29% |
| Q2 FY26 | $17K | 0% | +183% |
| Q4 FY25 | $17K | +183% | — |
| Q2 FY25 | $6K | — | — |
Q4 FY26 at a glance
Aytu Biopharma, Q4 FY26: revenue $16.1M (+6% year over year), operating margin -4.8%, net loss $15K, operating cash flow $4.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Aytu Biopharma's capital expenditures?
Aytu Biopharma's capital expenditures were $12K in Q4 FY26 (fourth quarter fiscal 2026), -29% from Q2 FY26.
How has Aytu Biopharma's capital expenditures changed?
Over the last 4 quarters it ranged from $6K (Q2 FY25) to $17K (Q2 FY26).